Replies to post #3963 on Gilead Sciences Inc (GILD)

[BottomBounce]

$GILD Gilead Sciences reports filgotinib demonstrated durable efficacy and consistent safety profile at 52 weeks in FINCH 1 and 3 studies in rheumatoid arthritis https://www.gilead.com/news-and-press/press-room/press-releases/2020/6/filgotinib-demonstrates-durable-efficacy-and-consistent-safety-profile-at-52-weeks-in-finch-1-and-3-studies-in-rheumatoid-arthritis

[LionsTact]

I appreciate your input...I really do...It's good to hear both sides as I try not to wear " rose colored glasses " with any stock .

.... I don't think exchanging views on a Large Cap message board ( positive or negative ) affects the PPS .....maybe on the OTC but not here....but good luck to those that think it does.

My portfolio is diverse enough for me not to lose sleep over GILD , but I do monitor my investments daily and in 20 years I've never married any stock

...I'm currently good with GILD.... Do I wish it were better ?...sure but no stock is perfect .

You Said:

Combining an antiviral that doesn't kill the virus with a drug that lowers immune response to the virus should make it interesting.

I think we should both leave that ( above quote ) up to the professionals that are conducting the tests as they're likely well aware of it .

... In the meantime hospitals around the world are using Remdesivir.

....Maybe you're money is against them, but money is on GILD and them getting the combination right.

... ( again ) I don't think exchanging views on a Large Cap message board ( positive or negative ) affects the PPS .....maybe on the OTC but not here....but good luck to those that think it does.

I wish you the best in your trades and looking forward to more opposing views .

Thanks for your post.

W.H.O. Coronavirus Disease (COVID-19) Dashboard Link:

https://covid19.who.int/?gclid=CjwKCAjw2uf2BRBpEiwA31VZj0uHnxGdMyV0sRoirjf3yoHUwZ4MwaL6HqzmG2Ex9qLDLV2hHv9bXBoCddQQAvD_BwE

[BottomBounce]

$GILD The Secretary of the Department of Health and Human Services has declared a public health emergency that justifies the emergency use of remdesivir to treat coronavirus disease 2019 COVID

https://www.gilead.com/remdesivir